Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Molecular Diagnostic Platform for Personalized Medicine for Acute Myeloid Leukemia

NCT04446741 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT04446741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04446741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Molecular Diagnostic Platform for Personalized Medicine for Acute Myeloid Leukemia
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2019
Completion date
October 31, 2022
Enrollment
2,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)